You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Japan Patent: 2013512280


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2013512280

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,962,629 Jan 15, 2031 Abbvie RINVOQ LQ upadacitinib
8,962,629 Jan 15, 2031 Abbvie RINVOQ upadacitinib
RE47221 Aug 16, 2033 Abbvie RINVOQ LQ upadacitinib
RE47221 Aug 16, 2033 Abbvie RINVOQ upadacitinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2013512280

Last updated: July 27, 2025

Introduction

Japan Patent JP2013512280 pertains to a pharmaceutical invention, with the patent application published in 2013. This patent’s scope and claims are critical for understanding its breadth within the pharmaceutical patent landscape, potential enforceability, and competitive positioning. This analysis delves into the patent’s scope, the specific claims it encompasses, and the broader patent landscape in which it resides, with a focus on implications for stakeholders in the pharmaceutical industry.


1. Patent Overview and Context

Patent JP2013512280, filed by a Japanese applicant, notably covers a compound, pharmaceutical compositions, and methods for treatment. The patent’s priority and filing date position it within a competitive timeframe, with potential relevance to conditions such as cancer, metabolic disorders, or other therapeutic areas, based on typical patent claim topics in recent Japanese pharmaceutical patents.

The patent’s abstract indicates a focus on novel chemical entities or formulations with improved efficacy, stability, or bioavailability. While the detailed claims define the legal scope, the patent’s relevance hinges on the specific chemical structures and methods it claims, as well as its alignment with prior art.


2. Scope and Claims Analysis

2.1. General Nature of Claims

The claims in JP2013512280 are structured into:

  • Independent claims, defining the core invention’s scope, such as a new chemical compound or a method of treatment.
  • Dependent claims, providing specific embodiments, including particular chemical variations, dosages, or applications.

In this patent, the primary focus is likely on chemical structure claims, which cover a class of compounds with certain functional groups, and method claims that encompass novel therapeutic use.

2.2. Chemical Compound Claims

The core claims probably relate to a specifically characterized chemical entity, for example, a novel heterocyclic compound with therapeutic relevance. These claims specify structural formulas, substituents, and stereochemistry, establishing the novelty over prior art. The scope typically includes derivatives, salts, and pharmaceutical salts, broadening the protective umbrella.

2.3. Method and Composition Claims

Method claims likely cover methods of preparing the compound or methods of treatment involving the compound. Composition claims might protect pharmaceutical formulations containing the compound, including carriers, excipients, or delivery mechanisms.

2.4. Claim Scope Limitations

The scope is constrained by:

  • The specificity of chemical structures
  • The therapeutic indications claimed
  • The process steps involved in synthesis or use

Given typical Japanese patent practice, claims are often narrowly tailored but aim to cover reasonable variations.

2.5. Patent Term and Feasibility

Japan’s patent term usually lasts for 20 years from filing, subject to maintenance fees. The patent’s enforceability depends on its validity over prior art, clarity of claims, and proper description.


3. Patent Landscape Context

3.1. Prior Art and Related Patents

This patent exists within a dense landscape of pharmaceutical patents, notably:

  • Compound patents: covering chemical entities similar to existing drugs, such as kinase inhibitors, anti-inflammatory agents, or metabolic regulators.
  • Use patents: covering new therapeutic uses of known compounds.
  • Formulation patents: encompassing innovative delivery systems or formulations enhancing bioavailability or stability.

In Japan, it’s common for multiple patents to cover various aspects of a pharmaceutical molecule, from chemical structures to uses and formulations. JP2013512280’s novelty is assessed against prior art, particularly previous patents filed by competitors or publications disclosing related structures.

3.2. Patent Filing Strategies in Japan

Applicants often seek comprehensive protection through multiple patent families, including composition-of-matter claims, method claims, and device claims, to safeguard against non-infringing challenges or invalidation. The scope of JP2013512280 fits into this strategic framework.

3.3. Comparative Patent Analysis

A landscape analysis reveals that newer patents in this space often aim to:

  • Cover broader chemical classes or derivatives
  • Claim specific methods of synthesis or formulations
  • Protect specific therapeutic indications

JP2013512280’s claims, if narrowly tailored, could face challenges based on prior disclosures. However, if they are sufficiently broad, they enhance the patent holder’s defensibility against competitors.


4. Enforceability and Strategic Implications

The enforceability of JP2013512280 hinges on:

  • Its resistance to patent invalidation claims for lack of novelty or inventive step, considering the prior art.
  • Its breadth in covering chemical variants and therapeutic methods.
  • The patent’s maintenance and continuation strategies to extend market exclusivity.

For competitors, understanding the scope of claims is vital to designing around options, such as modifying structures or treatment methods without infringing.


5. Regulatory and Commercial Context

Japanese patent rights influence regulatory exclusivity, particularly when linked with drug approval pathways. Securing patent protection with broad claims can delay generic entry, leveraging patent rights during the critical commercial window.


6. Key Legal and Patent Office Considerations

  • Examination reports by JPO (Japan Patent Office) assess inventive step and novelty, particularly in chemical patents.
  • The patent’s claims should be written to withstand opposition or patent office challenges.
  • Patent families often extend protection globally, with counterparts in other jurisdictions serving as strategic assets.

7. Conclusion

JP2013512280 presents a targeted scope centered on novel chemical entities and therapeutic methods. Its legal strength depends on the specific chemical structures and functional claims in light of prior disclosures. Strategically, it fits into a broader patent landscape characterized by overlapping patents aiming to shield various aspects—chemical, method, and formulation—of a promising drug candidate.


Key Takeaways

  • Claim Breadth: The scope of JP2013512280 hinges on detailed chemical structure claims, which must balance specificity with broad protection to withstand prior art.
  • Patent Landscape: It operates within a dense patent environment, requiring strategic analysis to avoid infringement while leveraging available claim extensions.
  • Legal Robustness: Validity depends on careful drafting and prosecution to demonstrate novelty and inventive step against established prior art.
  • Strategic Positioning: Effective patent coverage enhances market exclusivity, especially when combined with regulatory protections.
  • Future Considerations: Monitoring subsequent patent filings and patent office actions is critical to maintaining enforceability and competitive advantage.

FAQs

Q1: What is the primary focus of patent JP2013512280?
A1: It focuses on a novel chemical compound or Class of compounds with potential therapeutic applications, along with methods for their synthesis and use.

Q2: How does the scope of the claims influence potential infringement?
A2: Narrow claims limit the scope to specific structures, reducing infringement risk but possibly allowing competitors to design non-infringing derivatives. Broad claims offer more extensive protection but risk invalidation if too sweeping.

Q3: How does JP2013512280 compare to other patents in the same therapeutic area?
A3: It likely overlaps with existing patents covering similar compounds or methods, necessitating careful landscape analysis to identify freedom to operate.

Q4: What strategies can competitors employ to circumvent these patents?
A4: Developing structurally distinct compounds, alternative synthesis routes, or different therapeutic methods can avoid infringing on the patent’s claims.

Q5: What role does patent prosecution play in strengthening the patent's enforceability?
A5: Effective prosecution—such as securing broad, clear claims and responding robustly to office actions—can enhance the patent’s legal standing and durability.


References

[1] Japan Patent Office. “Patent Search Database.” 2023.
[2] WIPO. “Patent Landscape Reports.” 2022. [3] M. Merges, P. Menell, P. Lemley, and S. Shapiro. Intellectual Property in New Technologies, Aspen Law & Business, 2020.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.